Clinical trial
Panther (Personalised Antiplatelet Therapy for Patients With Symptomatic Peripheral Arterial Disease)
NCT06047002 is registered in ClinicalTrials.gov with University of Leicester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Panther (Personalised Antiplatelet Therapy for Patients With Symptomatic Peripheral Arterial Disease)
- Lead sponsor
- University of Leicester
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 29, 2022
- Completion date
- December 31, 2024
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.